High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.
AUTOR(ES)
Nos, C
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=486589Documentos Relacionados
- Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.
- Blood—Brain Barrier
- Blood—Brain Barrier
- High dose intravenous methyl prednisolone in acute exacerbations of multiple sclerosis.
- Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII